Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic, Idiopathic

Explore clinical trials studying Purpura, Thrombocytopenic, Idiopathic. Study availability and eligibility vary by location and protocol.

322 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic, Idiopathic trial results

Completed

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

NCT03939637

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix CHildren's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 27 locations
View Trial Details
Completed

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

NCT04943042

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Swedish Orphan Biovitrum Research Site 131 Zagreb, Croatia
  • Swedish Orphan Biovitrum Research Site 122 Brno, Czechia
  • Swedish Orphan Biovitrum Research Site 123 Ostrava, Czechia
  • Swedish Orphan Biovitrum Research Site 121 Prague, Czechia
View all 55 locations
View Trial Details
Completed

A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

NCT04278924

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Arizona Clinical Research Center - Hunt - PPDS Tucson, Arizona, United States
  • University of Florida Gainesville, Florida, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 55 locations
View Trial Details
Completed

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

NCT04346654

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
  • Novartis Investigative Site Aachen, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Donauwörth, Germany
View Trial Details
Completed

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

NCT05613296

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • AON SS. ANTONIO E BIAGIO E C. ARRIGO - SS emostasi e trombosi Alessandria, Italy
  • SOD Clinica Ematologica AOU Ospedali Riuniti Umberto I GM Lancisi G Salesi Ancona, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Policlinico S. Orsola Bologna, Italy
View all 21 locations
View Trial Details
Completed

Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

NCT02298075

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti Asti, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" Bologna, Italy
  • Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi Catania, Italy
  • Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano Florence, Italy
View all 13 locations
View Trial Details

Related conditions